Compare Gitcoin (GTC) vs Enzyme (MLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gitcoin vs Enzyme — how do they compare? Gitcoin trades at Rp1,419 (market cap Rp123,57M, Rp42,18M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Gitcoin and Enzyme are close in size by market cap, and Gitcoin's circulating supply is 87,5M GTC versus 3,3M MLN for Enzyme. Which is the better fit depends on your goals — on Pluang, investors hold Gitcoin for 24 Days and Enzyme for 29 Days on average.
| GTC | MLN | |
|---|---|---|
Market Cap | Rp123,57M | Rp134,13M |
Volume (24h) | Rp42,18M | Rp104,56M |
Circulating Supply | 87,5M GTC | 3,3M MLN |
Typical Hold Time | 24 Days | 29 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Gitcoin (GTC) is currently trading at Rp1,451, with a market cap of Rp126.9 million and a bearish technical signal. The price is at the pivot point, with support at Rp1,411 and resistance at Rp1,485. RSI indicators are neutral, while ADX signals a strong trend. Recent ecosystem activity includes ongoing grants rounds and developer engagement, though no major protocol upgrades were reported recently.
Overall outlook is cautious due to bearish technicals and low market cap, which increases volatility risk. Key opportunities lie in potential ecosystem growth from grant funding, but investors should be wary of thin liquidity and regulatory uncertainties in the crypto space.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Gitcoin
Gitcoin develops tools that help communities fund, build, and protect important projects. Its Gitcoin Grants Program has distributed over $54 million to early-stage builders supporting public goods in DeFi, climate, open source, and more. Key products include Gitcoin Grants Stack (a grants management platform), Allo Protocol (an open-source funding system), and Gitcoin Passport (a decentralized identity tool). GTC, Gitcoin’s governance token launched in May 2021, is used to create and fund the DAO that oversees Gitcoin.
Read more on GTC →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
